NCT07261852

Brief Summary

This study is a clinical trial that evaluates the best treatment option using a strength training protocol and an endurance training protocol in patients with lower limb amputations who use prostheses. The protocol consists of 6 weeks of strength training and 6 weeks of endurance training, with a 1-month washout period between the two.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
19mo left

Started Nov 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Nov 2025Dec 2027

First Submitted

Initial submission to the registry

September 22, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

November 30, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 3, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

December 3, 2025

Status Verified

October 1, 2025

Enrollment Period

2 years

First QC Date

September 22, 2025

Last Update Submit

November 28, 2025

Conditions

Keywords

amputeesquality of lifefuncionalitymuscle strengthmovilityendurance training

Outcome Measures

Primary Outcomes (2)

  • Changes in Funcionality

    It is assessed using the TUG test, which requires patients to get up from a chair, walk 3 meters, turn around, walk back to the chair, and sit down again. Patients will receive the following instructions: "Get up on the word 'go,' walk to the tape, turn around, walk back to the chair, and sit down."

    day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.

  • Changes in quality of life

    It is assessed using a self-administered questionnaire called WHOQOL-BREF, which provides a profile of the person's perceived quality of life.

    day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.

Secondary Outcomes (3)

  • Changes in Maximum isometric muscle strength

    day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.

  • Changes on Movility

    day 1, day 18 (last day of week 6), day 1 (after the wash out) and day 24.

  • Change in Global percepcion of change

    assessments were performed at the end each protocol. day 18 and day 24

Study Arms (2)

Muscle strength training

EXPERIMENTAL

Strength training lasts six weeks, during which submaximal strength percentages ranging from 75% to 90% are worked on. It is performed three times a week and follows a protocol consisting of progressive exercises for the large functional muscle groups relevant to the population being trained.

Other: Muscle strengh training

Endurance training

ACTIVE COMPARATOR

Resistance training will be carried out for 6 weeks, 3 times a week, with exercises prescribed by a protocol with training characteristics defined by bibliography found in the ACSM.

Other: Resistence training

Interventions

Resistance training will be carried out for 6 weeks, 3 times a week, with exercises prescribed by a protocol with training characteristics defined by bibliography found in the ACSM.

Endurance training

Strength training lasts six weeks, during which submaximal strength percentages ranging from 75% to 90% are worked on. It is performed three times a week and follows a protocol consisting of progressive exercises for the large functional muscle groups relevant to the population being trained.

Muscle strength training

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with unilateral lower limb amputation
  • Transtibial and/or transfemoral amputation
  • Prosthetized
  • Aged 18 to 75 years
  • Who sign the informed consent form

You may not qualify if:

  • That they are unable to complete the initial assessment
  • That they undergo further secondary training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Mauro S Barone

    Ugr

    STUDY DIRECTOR

Central Study Contacts

Gabriela B Dell´Elce

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

September 22, 2025

First Posted

December 3, 2025

Study Start

November 30, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

December 3, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

If necessary or required, informed consent and data analysis will be shared.

Shared Documents
SAP, ICF